Episode # 172 • 18 Jun 2024
Advancing Cancer Care: AUA 2024 Highlights in Prostate & Bladder Cancer
In this episode of the BackTable Urology, Dr. Bogdana Schmidt (University of Utah), Dr. Woodson Smelser (Washington University in St. Louis), and Dr. Jeff Tosoian (Vanderbilt University) discusses the latest insights and advancements in prostate and bladder cancer treatment presented at AUA 2024.
This podcast is supported by
Timestamps
00:00 - Introductions
03:06 - Prostate Cancer Screening Insights
10:10 - Advancements in MRI and Biomarkers
18:22 - Transperineal vs. Transrectal Prostate Biopsy
27:18 - New Guidelines for Bladder Cancer Treatment
30:57 - Innovative Drug Delivery Systems
32:36 - Gene Therapy and Immunotherapy Advances
40:11 - Concluding Thoughts and Future Prospects
Resources
You may also like
More about this episode
First, the doctors cover noteworthy topics, including the effectiveness of early screening and treatment for high-risk prostate cancer patients, innovative approaches in imaging and biomarkers, and the impact of new guidelines on salvage therapy. They also explore emerging treatments for non-muscle invasive bladder cancer (NMIBC), as well as the evolving role of systemic immunotherapies and advanced genomic testing. To wrap up, the urologists offer detailed analyses and their expert opinions on how these developments could transform patient care in the field of urologic oncology.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.